Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Exp Ther Med ; 11(6): 2519-2524, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27284342

ABSTRACT

Patients undergoing endoscopy frequently require sedation, which commonly includes the administration of midazolam or dexmedetomidine. Previous meta-analyses have mainly focused on comparing the effects of these two drugs in intensive care unit patients. In the present study, randomized controlled trials (RCTs) that compared the sedative and clinical effectiveness of these two drugs in patients undergoing endoscopy were searched in a number of databases. The meta-analysis showed that dexmedetomidine demonstrated a significantly lower rate of respiratory depression and adverse events compared with those presented upon midazolam administration. A significant difference was also observed in the sedation potency of the sedatives. The current controlled data suggest that dexmedetomidine may be an alternative to midazolam in the sedation for endoscopy. However, more high-quality and well-designed studies are required to further evaluate this conclusion.

3.
Can J Anaesth ; 61(5): 446-51, 2014 May.
Article in English | MEDLINE | ID: mdl-24585232

ABSTRACT

PURPOSE: Intravenous leiomyomatosis is a rare disorder characterized by benign smooth-muscle tumours, termed leiomyomas, which originate from uterine leiomyomas or pelvic veins. Tumours may extend into the right-sided heart chambers, termed intracardiac leiomyomatosis (ICLM), and may be potentially life-threatening due to mechanical interference with cardiac structures or pulmonary arteries. While surgical excision is the optimal therapy, incomplete retrieval of a tumour or fatal retroperitoneal hemorrhage may occur. We present a case where intraoperative transesophageal ultrasound (TEU) guided complete removal of an intracardiac leiomyoma in a single-stage surgery solely through the right atrium without vein injury. CLINICAL FEATURES: A 46-yr-old female patient presented with a two-week history of exertional dyspnea, palpitations, and syncope. Preoperative imaging modalities revealed a continuous solid mass extending from the inferior vena cava (IVC) into the right atrium, and the patient subsequently underwent open heart surgery for tumour removal and definitive diagnosis. A systematic intraoperative TEU examination performed before resection showed that the serpentine tumour was free from any attachment to the IVC and the heart. Furthermore, the diameter of the intracardiac end of the tumour was wider than that of the IVC. Given these findings, the surgeons carefully drew the cord-like tumour out of the right atrium under close TEU monitoring without vein injury. Post-extraction TEU examination showed complete removal of the tumour. Microscopic examination of the specimen confirmed the diagnosis of intravenous leiomyomatosis. CONCLUSIONS: For cases with ICLM, intraoperative TEU plays a significant role in helping to plan the surgical approach, monitor the movement of the tumour and the IVC during the extraction, and assess the completeness of tumour resection.


Subject(s)
Heart Neoplasms/surgery , Leiomyomatosis/surgery , Ultrasonography, Interventional/methods , Vascular Neoplasms/surgery , Dyspnea/etiology , Female , Heart Atria , Heart Neoplasms/diagnosis , Heart Neoplasms/diagnostic imaging , Humans , Leiomyomatosis/diagnosis , Leiomyomatosis/diagnostic imaging , Middle Aged , Treatment Outcome , Vascular Neoplasms/diagnosis , Vascular Neoplasms/diagnostic imaging , Vena Cava, Inferior
4.
J Neurosci Res ; 85(15): 3457-64, 2007 Nov 15.
Article in English | MEDLINE | ID: mdl-17497674

ABSTRACT

Glial cell line-derived neurotrophic factor (GDNF) promotes the survival and functions of neurons. It has been shown to be a promising candidate in the treatment of ischemia and other neurodegenerative diseases. We transfected mouse astrocytes in primary cultures with a human GDNF gene and found that their conditioned medium could not only support the growth and survival of cultured dopaminergic neurons but also protect astrocytes from staurosporine- and ischemia-induced apoptosis. This indicated that these transfected astrocytes could release GDNF. A similar protective effect on astrocytes against apoptosis was evident when recombinant human GDNF was used. Moreover, GDNF reduced caspase-3 activity but not that of caspase-1 in cultured astrocytes after ischemia treatment. Thus, GDNF protects astrocytes from apoptosis by inhibiting the activation of caspase-3.


Subject(s)
Apoptosis/physiology , Astrocytes/metabolism , Glial Cell Line-Derived Neurotrophic Factor/metabolism , Animals , Apoptosis/drug effects , Blotting, Western , Caspase 3/metabolism , Cells, Cultured , Enzyme Inhibitors/toxicity , Humans , In Situ Nick-End Labeling , Ischemia/physiopathology , Mice , Mice, Inbred ICR , Staurosporine/toxicity , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...